ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

September 29, 2006

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996

Plant-Based Diet Associated With Improved Survival

April 25, 2008

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000